Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | RARA | P10276 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | LDHB | P07195 | 1/20 | 0.41 |
| ▸ | BID | P55957 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29670029 | 1.00 | RARB (0.50) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL2967151 | 0.90 | RARB (0.47) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL1615392 | 0.85 | BID (0.49) | ALDH1A1MAPTBIDBCL2L1MCL1 | |
| SCHEMBL18543774 | 0.78 | RARB (0.49) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL28496833 | 0.78 | RARB (0.49) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL11094349 | 0.76 | ALDH1A1 (0.53) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL168254 | 0.75 | BID (0.48) | ALDH1A1MAPTBIDBCL2L1MCL1 | |
| SCHEMBL7944628 | 0.73 | BID (0.46) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL18481326 | 0.73 | OXER1 (0.44) | ALDH1A1LDHALDHBBIDBCL2L1 | |
| SCHEMBL6383337 | 0.73 | KAT8 (0.46) | RARBMAPTBIDBCL2L1MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240173229-A1 | METHODS OF SKIN WHITENING BY USE OF CANOLA EXTRACTS | 1242753 ONTARIO INC (CA) | 2024-05-30 | — | — | US | claimed |
| EP-3348251-B1 | SUNSCREEN COMPOSITIONS | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS US LLC (US) | 2024-01-17 | — | — | EP | claimed |
| EP-4223279-A1 | METHODS OF SKIN WHITENENING BY USE OF CANOLA EXTRACTS | 1242753 Ontario Inc. (CA) | 2023-08-09 | — | — | EP | claimed |
| WO-2022192882-A9 | TOPICAL COMPOSITIONS FOR UV PROTECTION | MARY KAY INC. (US) | 2023-03-23 | — | — | WO | claimed |
| EP-3578558-B1 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | 3V SIGMA SPA (IT) | 2021-02-24 | — | — | EP | claimed |
| EP-2961370-B1 | MICROCAPSULES COMPRISING SUNSCREEN AGENTS | TAGRA BIOTECHNOLOGIES LTD (IL) | 2020-12-23 | — | — | EP | claimed |
| EP-3578558-A1 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | 3V SIGMA S.p.A (IT) | 2019-12-11 | — | — | EP | claimed |
| EP-2853255-B1 | Method of formulating a personal care product with substantially no whitening effect when applied on wet skin and compositions thereof | HallStar Beauty and Personal Care Innovations Company (US) | 2018-11-28 | — | — | EP | claimed |
| EP-2488151-B1 | SUNSCREEN COMPOSITIONS | WYETH LLC (US) | 2018-02-28 | — | — | EP | claimed |
| EP-2427182-B1 | TOPICAL COMPOSITIONS COMPRISING INORGANIC PARTICULATES AND AN ALKOXYLATED DIPHENYLACRYLATE COMPOUND | ELC MAN LLC (US) | 2017-01-11 | — | — | EP | claimed |
| WO-2005065136-A2 | OIL IN SILICONE EMULSIONS AND COMPOSITIONS CONTAINING SAME | AVON PRODUCTS, INC. (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050142079-A1 | Oil in silicone emulsion and compositions containing same | AVON PRODUCTS INC. | 2005-06-30 | — | — | US | claimed |
| US-20050136014-A1 | Novel esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same | AVON PRODUCTS INC. | 2005-06-23 | — | — | US | claimed |
| EP-1458339-A1 | COSMETIC AND DERMATOLOGICAL LIGHT PROTECTION FORMULATIONS HAVING A CONTENT OF BENZOXAZOL DERIVATIVES | Beiersdorf AG (DE) | 2004-09-22 | — | — | EP | claimed |
| WO-2003084496-A1 | LIGHT-PROTECTIVE PREPARATIONS CONTAINING A PHOTOSTABLE UV-A FILTER | SYMRISE GMBH & CO. KG (DE) | 2003-10-16 | — | — | WO | claimed |
| WO-2003053390-A1 | COSMETIC AND DERMATOLOGICAL LIGHT PROTECTION FORMULATIONS HAVING A CONTENT OF BENZOXAZOL DERIVATIVES | BEIERSDORF AG (DE) | 2003-07-03 | — | — | WO | claimed |
| EP-1323410-A2 | Sunscreen emulsion composition and method of use | AVON PRODUCTS, INC. (US) | 2003-07-02 | — | — | EP | claimed |
| WO-2003051279-A2 | TOPICAL COMPOSITIONS AND METHODS OF APPLICATION | AVON PRODUCTS, INC. (US) | 2003-06-26 | — | — | WO | claimed |
| US-6555095-B1 | Containing a compound: L-A-H and A-L-H, wherein L is a lipophilic moiety, wherein A is an aromatic moiety having an ultraviolet absorption maximum between 290 nanometers and 400 nanometers, and wherein H is a hydrophilic moiety | AVON PRODUCTS, INC. | 2003-04-29 | — | — | US | claimed |
| US-6517816-B1 | Inner discontinuous phase and an outer continuous phase | AVON PRODUCTS, INC. | 2003-02-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136014-A1 | Novel esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same | TYR, NISCH, CUTA | RARB 108/4885MEN1 3495/4885ALDH1A1 599/4885 |
| US-20050142079-A1 | Oil in silicone emulsion and compositions containing same | CUTA, SRR, SMURF1 | RARB 336/4885MEN1 1976/4885ALDH1A1 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.